Clinical Trials Sponsored by GI Biome

Total 611 results

GI Biome, Inc.

Recruiting

Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer

Cancer | Colorectal Cancer | Rectal Cancer | Solid Tumor | Sigmoid Colon Cancer | Rectosigmoid Junction Cancer

Korea, Republic of
Seoul National University Hospital
GI Biome

Recruiting

The Effect of GI Biome #7 on Gut Microbiome and Health of the Elderly

Muscle Weakness

Korea, Republic of
GI Dynamics

Completed

Post Marketing Study in Subjects Who Have Type 2 Diabetes Using the EndoBarrier™ Gastrointestinal Liner

Obesity | Type 2 Diabetes

United Kingdom
GI Dynamics

Completed

Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity

Type II Diabetes

Netherlands
GI Dynamics

Completed

A Multicenter Study for Pre-Surgical Weight Loss

Obesity

Netherlands
GI Dynamics

Withdrawn

An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System (OLE)

Type 2 Diabetes
GI Dynamics

Completed

Study for Pre-Surgical Weight Loss in Type II Diabetes Patients

Obesity | Type 2 Diabetes

Brazil
GI Dynamics

Terminated

Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or Obesity

Obesity | Type 2 Diabetes
GI Dynamics

Completed

Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study

Type 2 Diabetes

Brazil
GI Dynamics

Completed

Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner

Obesity

Chile
GI Dynamics

Completed

Multi-Center Pre-Bariatric Weight Loss Study

Obesity

United States
GI Dynamics

Terminated

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese (ENDO)

Obesity | Type 2 Diabetes

United States
GI Dynamics

Completed

Study for Short Term Weight Loss in Candidates for Bariatric Surgery

Obesity

Chile
GI Dynamics

Completed

A Pilot Trial of the EndoBarrier™ Flow Restrictor for Glycemic Improvement in Type 2 Diabetics

Type 2 Diabetes

Chile
GI Cell, Inc.

Recruiting

A Study of GIC-102 (Allogeneic Natural Killer Cells) in Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, and Multiple Myeloma

Advanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin Lymphoma

Korea, Republic of
GI Windows, Inc.

Active, not recruiting

Procedure for Duodenal-Ileal Diversion With a Sleeve Gastrectomy for Patients With Obesity and Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes Mellitus

Canada
GI Windows, Inc.

Active, not recruiting

Procedure for Duodenal-Ileal Diversion for Patients With Weight Regain Following Sleeve Gastrectomy (SNAP-PS)

Obesity, Morbid

Spain
GI Windows, Inc.

Completed

A Trial of the Jejunal to Ileal Diversion Endoscopic Procedure (Side-to-Side Anastomosis)

Diabetes
GI Windows, Inc.

Recruiting

Early Feasibility for Safety & Device Functionality of SFM Anastomosis Device Used in 3 Procedures (SNAP-S) or (SNAP-PS) or (J-J) (GIW-SFM)

Morbid Obesity

India
GI Windows, Inc.

Recruiting

SEAM Trial: Sutureless End to End Anastomosis by Magnetic Compression (SEAM)

Retraction of Ileostomy

United States
GI Windows, Inc.

Active, not recruiting

Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve

Obesity, Morbid

United States
GI View Ltd.

Completed

Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients

Rectal Cancer | Colon Cancer

Israel
GI View Ltd.

Terminated

First in Man Aer-O-Scope

Screening Colonoscopy for Low Risk Subjects

Croatia
Stryker GI Ltd.

Unknown

ProtectiScope CS Intended for Diagnostic and Therapeutic Colonoscopy

Colon Cancer
GI Windows, Inc.

Recruiting

Early Feasibility Study: Assessment of Self-Forming Magnetic Anastomosis Device and Delivery System (SFM) in Obese Patients, When Used to Create a Duodenal-Ileal Anastomosis Post SG (SNAP-PS), or Used to Create a Jejuno-Jejunal (J-J) Anastomosis (GIW-J-J)

Obesity, Morbid

Chile
GI Innovation, Inc.

Recruiting

A Study to Evaluate the Safety and Therapeutic Activity of GI-102 in Patients With Advanced Solid Tumors

Advanced Solid Tumor | Metastatic Solid Tumor

Korea, Republic of, United States
GI Windows, Inc.

Active, not recruiting

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

Obesity | Type 2 Diabetes

Argentina
GI View Ltd.

Completed

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

Colonic Diseases | Colonic Polyp | Colon Cancer | Colonic Neoplasms | Colon Adenoma | Colon Disease | Colon Adenocarcinoma

Israel
GI View Ltd.

Terminated

Post Market Evaluation of Aer-O-Scope Visualization

Cancer

United States, Israel
GI Alliance
Sonic Incytes

Not yet recruiting

Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease

Non-alcoholic Fatty Liver Disease (NAFLD)

United States
GI Dynamics
Hospital Dipreca

Completed

A Study of the GI Sleeve for the Treatment of Type 2 Diabetes

Type 2 Diabetes
Hillmont GI
Ferring Pharmaceuticals

Completed

Effects and Tolerability With Clenpiq and Low Residue Diet

Colonoscopy Preparation

United States
Stanford University
GI Supply

Unknown

Prospective Evaluation of Stent Patency in Patients With Benign Biliary Obstruction of the Wing Biliary Stent (Viaduct™)

Bile Duct Stricture

United States
Motus GI Medical Technologies Ltd

Terminated

Demonstrating Effective Salvage of Inadequate Colonoscopies

Colorectal Screening

United States
Motus GI Medical Technologies Ltd

Terminated

Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation

CRC

Israel
Motus GI Medical Technologies Ltd

Withdrawn

Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who Are High Risk For Inadequate Bowel Preparation (RESCue)

Colorectal Cancer | Gastrointestinal Disease

United States
Motus GI Medical Technologies Ltd

Withdrawn

Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System

Gastrointestinal Diseases | Colorectal Cancer
Universitätsklinikum Hamburg-Eppendorf
GI Dynamics

Unknown

EndoBarrier Register Deutschland-Safety and Efficacy of the Endoscopic Duodenal-Jejunal Bypass Sleeve (EBRD)

Obesity | Diabetes Mellitus

Germany
GI Dynamics
Biostatistical Consulting, Inc.

Recruiting

EndoBarrier System Pivotal Trial(Rev E v2) (STEP-1)

Obesity | Diabetes type2

United States
Imelda GI Clinical Research Center

Completed

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis

Belgium
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the Motus Cleansing System (MCS) (MCS)

CRC

Netherlands, Germany
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus GI CleanUp System During Screening Colonoscopy

CRC
GI Dynamics
University of Malaya

Terminated

EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

Obesity | Type 2 Diabetes

Malaysia
Imelda GI Clinical Research Center

Completed

pAtient rePorted Outcomes Linked With histoLogy in Patients With uLcerative cOlitis (APOLLO)

Ulcerative Colitis

Belgium
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System

Colorectal Cancer | Gastrointestinal Disease

United States
Covidien, GI Solutions

Completed

Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia

ESOPHAGEAL SQUAMOUS CELL CARCINOMA

China
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the Motus Cleansing System (MSC)

Colonoscopy Procedure
Motus GI Medical Technologies Ltd

Completed

Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System

CRC

Israel
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

CRC

Spain
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the CleanC System-Israel

Colorectal Cancer (CRC) Screening

3

Subscribe